• Health & Medicine

Two targeted lung cancer drugs get initial ‘no’ for NHS in England

Patients with a certain type of lung cancer will not have access to two targeted cancer drugs on the NHS in England. Patients with a certain type of lung cancer will not have access to two targeted cancer drugs on the NHS in England.

12 April 2019

• Health & Medicine

Advanced breast cancer drug combo approved for NHS in England

A new drug combo has been made available to some patients with advanced breast cancer on the NHS in England. A new drug combo has been made available to some patients with advanced breast cancer on the NHS in England.

3 April 2019

• Health & Medicine

Targeted lymphoma drug gets green light for NHS in England

People with a certain type of lymphoma will now have access to a targeted cancer drug, called brentuximab vedotin, on the NHS in England. People with a certain type of lymphoma will now have access to a targeted cancer drug, called brentuximab vedotin, on the NHS in England.

22 March 2019

• Health & Medicine

Drug combination boosts kidney cancer survival in trials

Combining a targeted cancer drug with an immunotherapy extends the lives of advanced kidney cancer patients, according to two clinical trials. Combining a targeted cancer drug with an immunotherapy extends the lives of advanced kidney cancer patients, according to two clinical trials.

19 February 2019

• Health & Medicine

Targeted drug could extend lives of some women with advanced breast cancer

Combining a targeted drug with hormone therapy could extend survival for some women with advanced breast cancer, according to new trial results. Combining a targeted drug with hormone therapy could extend survival for some women with advanced breast cancer, according to new trial results.

23 October 2018

• Health & Medicine

Some people with advanced kidney cancer could avoid surgery

The targeted drug sunitinib is as effective alone as when it’s combined with surgery for some people with advanced kidney cancer. The targeted drug sunitinib is as effective alone as when it’s combined with surgery for some people with advanced kidney cancer.

3 June 2018

• Health & Medicine

Six months of breast cancer treatment ‘could be as effective as 12’ in some women with early stage disease

Six months of treatment could be as effective as 12 months for women with a type of early stage breast cancer, according to unpublished clinical trial results. Six months of treatment could be as effective as 12 months for women with a type of early stage breast cancer, according to unpublished clinical trial results.

16 May 2018

• Health & Medicine

Precision drug could treat different cancers with rare gene fault  

A new targeted drug could be used to treat a small number of advanced cancers no matter where they grow in the body, according to new trial results. A new targeted drug could be used to treat a small number of advanced cancers no matter where they grow in the body, according to new trial results.

22 February 2018

• Health & Medicine

Breast cancer drug approved for NHS in England

A drug for certain types of breast cancer has been approved for the NHS in England. A drug for certain types of breast cancer has been approved for the NHS in England.

2 February 2018

• Health & Medicine

Immunotherapy and targeted drugs could stop some melanomas from returning

Two clinical trials have found that existing treatments for advanced melanoma could stop the cancer returning in some people with earlier stage disease. Two clinical trials have found that existing treatments for advanced melanoma could stop the cancer returning in some people with earlier stage disease.

12 September 2017

• Health & Medicine

Two clinical trials show promise with different targeted drugs for lung cancer

Two drugs targeting different gene faults in lung cancer have shown potential to be better than those already available. Two drugs targeting different gene faults in lung cancer have shown potential to be better than those already available.

6 June 2017

• Health & Medicine

Ovarian cancer drug reduces chance certain advanced breast cancers will get worse

A drug that’s already approved to treat certain ovarian cancers holds some advanced breast cancers at bay longer than standard chemotherapy. A drug that’s already approved to treat certain ovarian cancers holds some advanced breast cancers at bay longer than standard chemotherapy.

4 June 2017